The National Institute for Health and Care Excellent (NICE) has approved the use of five home-testing devices to diagnose and assess the severity of obstructive sleep apnoea hypopnoea syndrome (OSAHS) ...
SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced its home ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback